Phenotype-Driven Plasma biobanking strategies and Methods

Journal of Personalized Medicine

Volumn 5, Issue 2, 2015, Pages 140-152

  Bowton, Erica A ^a   Collier, Sarah P ^a   Wang, Xiaoming ^a   Sutcliffe, Cara B ^a   Van Driest, Sara L ^b   Couch, Lindsay J ^a   Herrera, Miguel ^a   Jerome, Rebecca N ^a   Slebos, Robbert J C ^a,c   Alborn, William E ^a,c   Liebler, Daniel C ^a,c   McNaughton, Candace D ^a   Mernaugh, Ray L ^c   Wells, Quinn S ^b,c   Brown, Nancy J ^c   Roden, Dan M ^c   Pulley, Jill M ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biobanking; Biorepository; BioVU; Plasma; Proteomics

Indexed keywords

ARTICLE; CLINICAL DATA REPOSITORY; CLINICAL RESEARCH; CLINICAL STUDY; DNA BIOBANK; ELECTRONIC MEDICAL RECORD; GENE INTERACTION; GENOMICS; HEALTH CARE FACILITY; HEALTH PROGRAM; HUMAN; MEDICAL PROCEDURES; PERSONALIZED MEDICINE; PHENOTYPE; PLASMA BIOBANK; PLASMA COLLECTION; TREATMENT OUTCOME;

EID: 84994612842     PISSN: None     EISSN: 20754426     Source Type: Journal    
DOI: 10.3390/jpm5020140     Document Type: Article

References (23)

1. Ritchie, M.D.; Denny, J.C.; Crawford, D.C.; Ramirez, A.H.; Weiner, J.B.; Pulley, J.M.; Basford, M.A.; Brown-Gentry, K.; Balser, J.R.; Masys, D.R.; et al. Robust replication of genotype-phenotype associations across multiple diseases in an electronic medical record. Am. J. Hum. Genet. 2010, 86, 560-572.
2. Heatherly, R.D.; Loukides, G.; Denny, J.C.; Haines, J.L.; Roden, D.M.; Malin, B.A. Enabling genomic-phenomic association discovery without sacrificing anonymity. PLOS One 2013, 8, e53875.
3. McGregor, T.L.; van Driest, S.L.; Brothers, K.B.; Bowton, E.A.; Muglia, L.J.; Roden, D.M. Inclusion of pediatric samples in an opt-out biorepository linking DNA to de-identified medical records: pediatric BioVU. Clin. Pharmacol. Ther. 2013, 93, 204-211.
4. Pulley, J.; Clayton, E.; Bernard, G.R.; Roden, D.M.; Masys, D.R. Principles of human subjects protections applied in an opt-out, de-identified biobank. Clin. Transl. Sci. 2010, 3, 42-48.
5. Pulley, J.M.; Denny, J.C.; Peterson, J.F.; Bernard, G.R.; Vnencak-Jones, C.L.; Ramirez, A.H.; Delaney, J.T.; Bowton, E.; Brothers, K.; Johnson, K.; et al. Operational implementation of prospective genotyping for personalized medicine: The design of the Vanderbilt PREDICT project. Clin. Pharmacol. Ther. 2012, 92, 87-95.
6. Roden, D.M.; Pulley, J.M.; Basford, M.A.; Bernard, G.R.; Clayton, E.W.; Balser, J.R.; Masys, D.R. Development of a large-scale de-identified DNA biobank to enable personalized medicine. Clin. Pharmacol. Ther. 2008, 84, 362-369.
7. Bowton, E.; Field, J.R.; Wang, S.; Schildcrout, J.S.; Van Driest, S.L.; Delaney, J.T.; Cowan, J.; Weeke, P.; Mosley, J.D.; Wells, Q.S.; et al. Biobanks and electronic medical records: Enabling cost-effective research. Sci. Transl. Med. 2014, 6, doi:10.1126/scitranslmed.3008604.
8. Chen, H.; Zhu, Z.; Zhu, Y.; Wang, J.; Mei, Y.; Cheng, Y. Pathway mapping and development of disease-specific biomarkers: Protein-based network biomarkers. J. Cell. Mol. Med. 2015, 19, 297-314.
9. Anderson, N.L. The clinical plasma proteome: A survey of clinical assays for proteins in plasma and serum. Clin. Chem. 2010, 56, 177-185.
10. Kiddle, S.J.; Sattlecker, M.; Proitsi, P.; Simmons, A.; Westman, E.; Bazenet, C.; Nelson, S.K.; Williams, S.; Hodges, A.; Johnston, C.; et al. Candidate blood proteome markers of Alzheimer's disease onset and progression: A systematic review and replication study. J. Alzheimers Dis. 2014, 38, 515-531.
11. Jacobs, J.M.; Adkins, J.N.; Qian, W.-J.; Liu, T.; Shen, Y.; Camp, D.G.; Smith, R.D. Utilizing human blood plasma for proteomic biomarker discovery. J. Proteome Res. 2005, 4, 1073-1085.
12. Anderson, N.L.; Anderson, N.G. The human plasma proteome: History, character, and diagnostic prospects. Mol. Cell. Proteomics 2002, 1, 845-867.
13. Zimmerman, L.J.; Li, M.; Yarbrough, W.G.; Slebos, R.J.C.; Liebler, D.C. Global stability of plasma proteomes for mass spectrometry-based analyses. Mol. Cell. Proteomics 2012, 11, doi:10.1074/mcp.M111.014340.
14. Villanueva, J.; Shaffer, D.R.; Philip, J.; Chaparro, C.A.; Erdjument-Bromage, H.; Olshen, A.B.; Fleisher, M.; Lilja, H.; Brogi, E.; Boyd, J.; et al. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J. Clin. Investig. 2006, 116, 271-284.
15. Marshall, J.; Kupchak, P.; Zhu, W.; Yantha, J.; Vrees, T.; Furesz, S.; Jacks, K.; Smith, C.; Kireeva, I.; Zhang, R.; et al. Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction. J. Proteome Res. 2003, 2, 361-372.
16. Koomen, J.M.; Li, D.; Xiao, L.; Liu, T.C.; Coombes, K.R.; Abbruzzese, J.; Kobayashi, R. Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery. J. Proteome Res. 2005, 4, 972-981.
17. Borges, C.R.; Rehder, D.S.; Jensen, S.; Schaab, M.R.; Sherma, N.D.; Yassine, H.; Nikolova, B.; Breburda, C. Elevated plasma albumin and apolipoprotein A-I oxidation under suboptimal specimen storage conditions. Mol. Cell. Proteomics 2014, 13, 1890-1899.
18. Aguilar-Mahecha, A.; Kuzyk, M.A.; Domanski, D.; Borchers, C.H.; Basik, M. The Effect of Pre-Analytical Variability on the Measurement of MRM-MS-Based Mid- to High-Abundance Plasma Protein Biomarkers and a Panel of Cytokines. PLOS One 2012, 7, e38290.
19. Betsou, F.; Gunter, E.; Clements, J.; DeSouza, Y.; Goddard, K.A.B.; Guadagni, F.; Yan, W.; Skubitz, A.; Somiari, S.; Yeadon, T.; et al. Identification of Evidence-Based Biospecimen Quality-Control Tools. J. Mol. Diagn. 2013, 15, 3-16.
20. Skogstrand, K.; Ekelund, C.K.; Thorsen, P.; Vogel, I.; Jacobsson, B.; Nørgaard-Pedersen, B.; Hougaard, D.M. Effects of blood sample handling procedures on measurable inflammatory markers in plasma, serum and dried blood spot samples. J. Immunol. Methods 2008, 336, 78-84.
21. Clark, S.; Youngman, L.D.; Palmer, A.; Parish, S.; Peto, R.; Collins, R. Stability of plasma analytes after delayed separation of whole blood: Implications for epidemiological studies. Int. J. Epidemiol. 2003, 32, 125-130.
22. Ostroff, R.; Foreman, T.; Keeney, T.R.; Stratford, S.; Walker, J.J.; Zichi, D. The stability of the circulating human proteome to variations in sample collection and handling procedures measured with an aptamer-based proteomics array. J. Proteomics 2010, 73, 649-666.
23. Pasella, S.; Baralla, A.; Canu, E.; Pinna, S.; Vaupel, J.; Deiana, M.; Franceschi, C.; Baggio, G.; Zinellu, A.; Sotgia, S.; et al. Pre-analytical stability of the plasma proteomes based on the storage temperature. Proteome Sci. 2013, 11, doi:10.1186/1477-5956-11-10.